Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

Cited by (1,001)

Items 201–300 of 1,001

1. A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome
   Viji Nair, Claudiu V. Komorowsky, E. Jennifer Weil, Berne Yee, Jeffrey B. Hodgin, Jennifer L. Harder, Bradley Godfrey, Wenjun Ju, Carine Boustany, Margrit Schwarz et al. · 2017 · Kidney International
2. A Personalized Approach to Chronic Kidney Disease and Cardiovascular Disease: JACC Review Topic of the Week.
   Ashton C. Lai, Solomon W. Bienstock, Raman Sharma, K. Skorecki, F. Beerkens, R. Samtani, A. Coyle, Tonia Kim, U. Baber, A. Camaj et al. · 2021 · Journal of the American College of Cardiology
3. Renal-Cardiac Crosstalk in the Pathogenesis and Progression of Heart Failure
   Heidi Noels, Emiel P. C. van der Vorst, Sébastien Rubin, Amber Emmett, Nikolaus Marx, Maciej Tomaszewski, Joachim Jankowski · 2025 · Circulation Research
4. Chronic kidney disease, cardiovascular disease and mortality: A prospective cohort study in a multi-ethnic Asian population
   Cynthia Ciwei Lim, Boon Wee Teo, Peng Guan Ong, Carol Yim-lui Cheung, Su Chi Lim, Khuan Yew Chow, Chan Choon Meng, Jeannette Lee, E Shyong Tai, Tien Yin Wong et al. · 2014 · European Journal of Preventive Cardiology
5. Aberrantly glycosylated IgG elicits pathogenic signaling in podocytes and signifies lupus nephritis
   Rhea Bhargava, Sylvain D. Lehoux, Kayaho Maeda, Maria Tsokos, Suzanne Krishfield, Lena Ellezian, Martin R. Pollak, Isaac Ely Stillman, Richard D. Cummings, George C. Tsokos · 2021 · JCI Insight
6. Interplay between periodontitis and chronic kidney disease
   Iain Chapple, Josefine Hirschfeld, Paul Cockwell, Thomas Dietrich, Praveen Sharma · 2024 · Nature Reviews Nephrology
7. High Glucose Induces Podocyte Injury via Enhanced (Pro)renin Receptor-Wnt-β-Catenin-Snail Signaling Pathway
   Caixia Li, Helmy M. Siragy · 2014 · PLoS ONE
8. Comprehensive Care Models for Cardiometabolic Disease
   Cara Reiter–Brennan, Omar Dildar a Dzaye, Dorothy M. Davis, Mike Blaha, Robert H. Eckel · 2021 · Current Cardiology Reports
9. Insulin Sensitivity and Albuminuria: The RISC Study
   Stefan Pilz, Femke Rutters, Giel Nijpels, Coen D.A. Stehouwer, Kurt Højlund, John J. Nolan, Beverley Balkau, Jacqueline M. Dekker, the RISC Investigators · 2014 · Diabetes Care
10. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria
    Giuseppe Mulè, Antonella Castiglia, Claudia Cusumano, Emilia Scaduto, Giulio Geraci, Dario C. Altieri, Epifanio Di Natale, Onofrio Cacciatore, Giovanni Cerasola, Santina Cottone · 2016 · Advances in experimental medicine and biology
11. Association of systemic immune-inflammation index and systemic inflammation response index with chronic kidney disease: observational study of 40,937 adults
    Peixian Huang, Yanpei Mai, Jun Fang Zhao, Yushan Yi, Yaqing Wen · 2024 · Inflammation Research
12. Blood Pressure, Hypertension, RAAS Blockade, and Drug Therapy in Diabetic Kidney Disease
    Hala Yamout, Ivana Lazich, George L. Bakris · 2014 · Advances in Chronic Kidney Disease
13. Impact of hypertension on mortality and cardiovascular disease burden in patients with cardiovascular risk factors from a general practice setting
    Josep Redón, María Téllez-Plaza, Domingo Orozco‐Beltrán, Vicente Francisco Gil-Guillén, Salvador Pita Fernández, Jorge Navarro-Pérez, Vicente Pallarés‐Carratalá, Francisco Valls, Antonio García Fernández, Ana María Perez-Navarro et al. · 2016 · Journal of Hypertension
14. Renal Benefits of SGLT 2 Inhibitors and GLP-1 Receptor Agonists: Evidence Supporting a Paradigm Shift in the Medical Management of Type 2 Diabetes
    Vjera Ninčević, Tea Omanović Kolarić, Hrvoje Roguljić, Tomislav Kizivat, Martina Smolić, Ines Bilić-Čurčić · 2019 · International Journal of Molecular Sciences
15. Effect of tirzepatide on albuminuria levels and renal function in patients with type 2 diabetes mellitus: A systematic review and multilevel meta‐analysis
    Paschalis Karakasis, Dimitrios Patoulias, Nikolaos Fragakis, Aleksandra N. Klisic, Manfredi Rizzo · 2023 · Diabetes Obesity and Metabolism
16. Chronic kidney disease in type 2 diabetes: Lessons from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study
    Giuseppe Pugliese, Anna Solini, Enzo Bonora, Cecilia Fondelli, Emanuela Orsi, Antonio Nicolucci, Giuseppe Penno · 2014 · Nutrition Metabolism and Cardiovascular Diseases
17. Remnant Cholesterol and Cardiovascular Mortality in Patients With Type 2 Diabetes and Incident Diabetic Nephropathy
    Dahai Yu, Zheng Wang, Xiaoxue Zhang, Bingjie Qu, Yamei Cai, Shuang Ma, Zhanzheng Zhao, David S Simmons · 2021 · The Journal of Clinical Endocrinology & Metabolism
18. An overview on safety issues related to erythropoiesis-stimulating agents for the treatment of anaemia in patients with chronic kidney disease
    Lucia Del Vecchio, Francesco Locatelli · 2016 · Expert Opinion on Drug Safety
19. Association of Retinal Age Gap and Risk of Kidney Failure: A UK Biobank Study
    Shiran Zhang, Ruiye Chen, Yan Wang, Wenyi Hu, Katerina Kiburg, Junyao Zhang, Xiaohong Yang, Honghua Yu, Mingguang He, Wei Wang et al. · 2022 · American Journal of Kidney Diseases
20. Combination therapy: an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease
    Radica Z. Alicic, Joshua J. Neumiller, Katherine R. Tuttle · 2025 · Nephrology Dialysis Transplantation
21. Prediction of 1-Year Mortality in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
    Vasim Farooq, Yvonne Vergouwe, Philippe Généreux, Christos V. Bourantas, Tullio Palmerini, Adriano Mendes Caixeta, Héctor M. García‐García, Roberto Diletti, Marie‐Angèle Morel, Thomas McAndrew et al. · 2013 · JACC: Cardiovascular Interventions
22. Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study
    Giuseppe Penno, Anna Solini, Enzo Bonora, Emanuela Orsi, Cecilia Fondelli, Gianpaolo Zerbini, Roberto Trevisan, Monica Vedovato, Franco Luigi Cavalot, Luigi Laviola et al. · 2018 · Acta Diabetologica
23. DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases
    Handelsman, Yehuda, Anderson, John E., Bakris, George L., Ballantyne, Christie M., Beckman, Joshua A., Bhatt, Deepak L., Bloomgarden, Zachary T., Bozkurt, Biykem, Budoff, Matthew J., Butler, Javed et al. · 2022 · Journal of Diabetes and its Complications
24. Dysfunctional high-density lipoproteins in children with chronic kidney disease
    Ryohei Kaseda, Kathy L. Jabs, Tracy Earl Hunley, Deborah P. Jones, Aihua Bian, Ryan M. Allen, Kasey C. Vickers, Patricia G. Yancey, MacRae F. Linton, Sergio Fazio et al. · 2014 · Metabolism
25. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients
    Naohito Isoyama, Paul B. Leurs, Abdul Rashid Qureshi, Annette N. Bruchfeld, Björn Anderstam, Olof Heimbürger, Peter F. Barany, Peter Stenvinkel, Bengt Lindholm · 2014 · Nephrology Dialysis Transplantation
26. Cystatin C– and Creatinine-Based Estimated Glomerular Filtration Rate, Vascular Disease, and Mortality in Persons With Diabetes in the U.S.
    Ching-Wei Tsai, Morgan Erika Grams, Lesley A. Inker, Josef Coresh, Elizabeth Selvin · 2013 · Diabetes Care
27. Predictors of chronic kidney disease in type 2 diabetes
    Salvatore De Cosmo, Francesca Chiara Viazzi, Antonio Pacilli, Carlo Bruno Giorda, Antonio Ceriello, Sandro Gentile, Giuseppina Tiziana Russo, Maria Chiara Rossi, Antonio Nicolucci, Pietro Guida et al. · 2016 · Medicine
28. Management and outcomes of acute myocardial infarction in patients with chronic kidney disease
    Nathaniel Rosso Smilowitz, Navdeep Gupta, Yu Guo, Rina Mauricio, Sripal Bangalore · 2016 · International Journal of Cardiology
29. Inhibiting NADPH Oxidases to Target Vascular and Other Pathologies: An Update on Recent Experimental and Clinical Studies
    Anthony L. Sylvester, David X. Zhang, Sophia Ran, Natalya S. Zinkevich · 2022 · Biomolecules
30. Past Decline Versus Current eGFR and Subsequent Mortality Risk
    David M. J. Naimark, Morgan Erika Grams, Kunihiro Matsushita, Corri Black, Iefke Drion, Caroline S. Fox, Lesley A. Inker, Areef Ishani, Sun Ha Jee, Akihiko Kitamura et al. · 2015 · Journal of the American Society of Nephrology
31. Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses
    Liam Gaziano, Luanluan Sun, Matthew Arnold, Steven Bell, Kelly Cho, Stephen K. Kaptoge, Rebecca J. Song, Stephen Burgess, Daniel C. Posner, Katja Mosconi et al. · 2022 · Circulation
32. Low-dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: a randomized controlled trial
    Richard F. Hobbs, Richard J. McManus, Clare J Taylor, Nicholas Robert Jones, Joy K Rahman, Jane L. Wolstenholme, Sungwook Kim, Joseph Kwon, Louise Jones, Jennifer A. Hirst et al. · 2024 · Nature Medicine
33. High prevalence of chronic kidney disease in a community survey of urban Bangladeshis: a cross-sectional study
    Shuchi Anand, Masuma Akter Khanam, Juliann Saquib, Nazmus Saquib, Tahmeed Ahmed, Dewan Shamsul Alam, Mark R. Cullen, Michèle Barry, Glenn Matthew Chertow · 2014 · Globalization and Health
34. Long‐Term Effects of Renal Sympathetic Denervation on Hypertensive Patients With Mild to Moderate Chronic Kidney Disease
    Kiuchi, Márcio Galindo, Graciano, Miguel Luis, Carreira, Maria Angela Magalhães de Queiroz, Kiuchi, Tetsuaki, Chen, Shaojie, Lugon, Jocemir Ronaldo · 2016 · The Journal of Clinical Hypertension
35. Renal effects of canagliflozin in type 2 diabetes mellitus
    Vlado Perkovic, Meg Jardine, Ujjwala Vijapurkar, Gary E. Meininger · 2015 · Current Medical Research and Opinion
36. Resveratrol: Evidence for Its Nephroprotective Effect in Diabetic Nephropathy
    Vemana Gowd, Qingzheng Kang, Qi Wang, Qiang Wang, Feng Chen, Ka‐Wing Cheng · 2020 · Advances in Nutrition
37. Risk factors of chronic kidney disease among type 2 diabetic patients with longer duration of diabetes
    Siddiqui, Khalid, George, Teena P., Joy, Salini S., Alfadda, Assim A. · 2022 · Frontiers in Endocrinology
38. End-Stage Renal Disease After Renal Surgery in Patients with Normal Preoperative Kidney Function: Balancing Surgical Strategy and Individual Disorders at Baseline
    Umberto Capitanio A, Alessandro Larcher, Carlo Terrone, Alessandro Antonelli, Alessandro Volpe, Cristian Fiori, Maria Furlan, Federico Dehò, Andrea Minervini, Sergio Serni et al. · 2016 · European Urology
39. Fisetin supplementation prevents high fat diet-induced diabetic nephropathy by repressing insulin resistance and RIP3-regulated inflammation
    Chenxu Ge, Minxuan Xu, Yuting Qin, Ting-Ting Gu, Deshuai Lou, Qiang Li, Linfeng Hu, Xuyuan Nie, Mingxing Wang, Jun Tan · 2019 · Food & Function
40. Targeting inflammation for the treatment of Diabetic Kidney Disease: a five-compartment mechanistic model
    Alexis Hofherr, Julie H. Williams, Li‐Ming Gan, Magnus P. Söderberg, Pernille Hansen, Kevin J. Woollard · 2022 · BMC Nephrology
41. Phosphate binders affect vitamin K concentration by undesired binding, an in vitro study
    Aegida Neradová, Stefan P. Schumacher, Isabelle Hubeek, Petra Lux, Leon J. Schurgers, Marc G. Vervloet · 2017 · BMC Nephrology
42. Targeting Redox Imbalance as an Approach for Diabetic Kidney Disease
    Keiichiro Matoba, Yusuke Takeda, Yosuke Nagai, Tamotsu Yokota, Kazunori Utsunomiya, Rimei Nishimura · 2020 · Biomedicines
43. Genetics of cardiovascular and renal complications in diabetes
    Ronald C.W. · 2015 · Journal of Diabetes Investigation
44. Filtration Markers as Predictors of ESRD and Mortality in Southwestern American Indians With Type 2 Diabetes
    Meredith C. Foster, Lesley A. Inker, Chi‐yuan Hsu, John H. Eckfeldt, Andrew S. Levey, Meda E. Pavkov, Bryan D. Myers, Peter H. Bennett, Paul L. Kimmel, Ramachandran Srini Vasan et al. · 2015 · American Journal of Kidney Diseases
45. Prevalence of chronic kidney disease in a representative sample of the Polish population: results of the NATPOL 2011 survey
    Łukasz Zdrojewski, Tomasz Roman Zdrojewski, Marcin Rutkowski, Piotr Bandosz, Ewa Król, Bogdan Wyrzykowski, Bolesław Rutkowski · 2015 · Nephrology Dialysis Transplantation
46. Aspirin and cardiovascular primary prevention in non-endstage chronic kidney disease: A meta-analysis
    Rupert Major, Issaam Oozeerally, Simon Dawson, Helen Riddleston, Laura J. Gray, Nigel John Brunskill · 2016 · Atherosclerosis
47. Adherence to Chronic Kidney Disease Screening Guidelines Among Patients With Type 2 Diabetes in a US Administrative Claims Database
    Kerstin Folkerts, Natalia Petruski‐Ivleva, Erin Comerford, Michael Blankenburg, Thomas Evers, Alain Gay, Linda F. Fried, Csaba Pal Kovesdy · 2021 · Mayo Clinic Proceedings
48. The Role of Biofactors in Diabetic Microvascular Complications
    Dan Ziegler, Massimo Porta, Νικόλαος Παπάνας, Maria Moța, György Jermendy, Elena Beltramo, Aurora Mazzeo, Andrea Caccioppo, Elio Striglia, Victoria A Serhiyenko et al. · 2021 · Current Diabetes Reviews
49. Activation of TRPV4 by dietary apigenin antagonizes renal fibrosis in deoxycorticosterone acetate (DOCA)–salt-induced hypertension
    Xing Wei, Peng Gao, Yunfei Pu, Qiang Li, Tao Yang, Hexuan Zhang, Shiqiang Xiong, Yuanting Cui, Li Li, Xin Ma et al. · 2017 · Clinical Science
50. Amount and pattern of physical activity and sedentary behavior are associated with kidney function and kidney damage: The Maastricht Study
    Remy J.H. Martens, Julianne D. van der Berg, Coen D.A. Stehouwer, Ronald M.A. Henry, Hans Bosma, Pieter C. Dagnelie, MARTIEN C. J. M. VAN DONGEN, Simone J. P. M. Eussen, Miranda T. Schram, Simone J. S. Sep et al. · 2018 · PLoS ONE
51. Diabetes mellitus type 2 in adults
    Ivan Ivanovich Dedov, Marina Vladimirovna Shestakova, Alexander Yu. Mayorov, Минара Шамхаловна Шамхалова, Olga Yu. Sukhareva, Gagik Radikovich Galstyan, Alla Yur'evna Tokmakova, Tatiana Vasil'evna Nikonova, Elena Viktorovna Surkova, Ирина Владимировна Кононенко et al. · 2020 · Diabetes Mellitus
52. Biotechnological challenges of bioartificial kidney engineering
    Jitske Jansen, Michele Fedecostante, Martijn J. G. Wilmer, Lambertus P. van den Heuvel, Joost G.J. Hoenderop, Rosalinde Masereeuw · 2014 · Biotechnology Advances
53. Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein
    Valentina Kon, Haichun Yang, Sergio Fazio · 2015 · Archives of Medical Research
54. Dipeptidyl peptidase-4 inhibition in chronic kidney disease and potential for protection against diabetes-related renal injury
    Giuseppe Penno, Monia Garofolo, Stefano Del Prato · 2016 · Nutrition Metabolism and Cardiovascular Diseases
55. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank
    Qiao Jin, Andrea O. Y. Luk, Eric S. H. Lau, Claudia H.T. Tam, Risa Ozaki, Cadmon K.P. Lim, Hongjiang Wu, Guozhi Jiang, Elaine Chow, Jack Kit‐Chung Ng et al. · 2022 · American Journal of Kidney Diseases
56. Vascular calcification in CKD: New insights into its mechanisms
    Nannan Ding, Yaodong Lv, Hong Su, Ziyang Wang, Xianglei Kong, Junhui Zhen, Zhimei Lv, Rong Wang · 2023 · Journal of Cellular Physiology
57. A population-based study on the prevalence and incidence of chronic kidney disease in the Netherlands
    Jan C. van Blijderveen, Sabine M. J. M. Straus, Robert Zietse, Bruno H. Ch. Stricker, Miriam Sturkenboom, Katia M.C. Verhamme · 2013 · International Urology and Nephrology
58. Association of uric acid, atherogenic index of plasma and albuminuria in diabetes mellitus.
    Emin Murat Akbaş, Aysu Timuroğlu, Adalet Özçiçek, Fatih Özçıçek, Levent Demirtaş, Âdem Güngör, Nergis Akbaş · 2014 · PubMed Central
59. Impact of extended ginsenoside Rb1 on early chronic kidney disease: a randomized, placebo-controlled study
    Xuefang Xu, Qian-Di Lu, Jingyue Wu, Yixiang Li, Jinzhu Sun · 2016 · Inflammopharmacology
60. Dental implant treatment for renal failure patients on dialysis: a clinical guideline
    Quan Yuan, Qiuchan Xiong, Megha Gupta, Rosa María López‐Pintor, Xiao-Lei Chen, Dutmanee Seriwatanachai, Michael Densmore, Yi Man, Ping Gong · 2017 · International Journal of Oral Science
61. Guanidinylations of albumin decreased binding capacity of hydrophobic metabolites
    Marieke Rueth, H.‐D. Lemke, Christian Preisinger, Detlef H. Krieter, Wendy Theelen, Prathibha Reddy Gajjala, E. Devine, Walter Zidek, Joachim Jankowski, Vera Jankowski · 2015 · Acta Physiologica
62. Ethnic disparities in risk of cardiovascular disease, end‐stage renal disease and all‐cause mortality: a prospective study among Asian people with Type 2 diabetes
    Jianjun Liu, Su Chi Lim, Lee Ying Yeoh, C. Su, Bee‐Choo Tai, Serena KM Low, Sharon Fun, S. Tavintharan, Kee Seng Chia, E Shyong Tai et al. · 2015 · Diabetic Medicine
63. Estimated Glomerular Filtration Rate, All-Cause Mortality and Cardiovascular Diseases Incidence in a Low Risk Population: The MATISS Study
    Chiara Donfrancesco, Simonetta Palleschi, Luigi Palmieri, Bárbara Rossi, Cinzia Lo Noce, Fabio Pannozzo, Belinda Spoto, Giovanni Tripepi, Carmine Zoccali, Simona Giampaoli · 2013 · PLoS ONE
64. MAFLD and CKD: An Updated Narrative Review
    Alessandro Mantovani, Rosa Lombardi, Filippo Cattazzo, Chiara Zusi, Davide Cappelli, Andrea Dalbeni · 2022 · International Journal of Molecular Sciences
65. The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank
    Theresa Hydes, Oliver John Kennedy, Ryan Malcolm Buchanan, Daniel James Cuthbertson, Julie Parkes, Simon DS Fraser, Paul J. Roderick · 2023 · BMC Medicine
66. Sympathetic Hyperactivity in Chronic Kidney Disease: Pathophysiology and (New) Treatment Options
    Eva E. Vink, Rosa L. de Jager, Peter J. Blankestijn · 2013 · Current Hypertension Reports
67. Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: insights from the Associazione Medici Diabetologi Annals initiative
    Salvatore De Cosmo, Francesca Chiara Viazzi, Antonio Pacilli, Carlo Bruno Giorda, Antonio Ceriello, Sandro Gentile, Giuseppina Tiziana Russo, Maria Chiara Rossi, Antonio Nicolucci, Pietro Guida et al. · 2015 · Nephrology Dialysis Transplantation
68. Association Between Urinary Sodium, Creatinine, Albumin, and Long-Term Survival in Chronic Kidney Disease
    Emily P. McQuarrie, Jamie P. Traynor, Alison H. M. Taylor, E. Marie Freel, Jonathan G. Fox, Alan G. Jardine, Patrick Barry Mark · 2014 · Hypertension
69. Association between Sarcopenia and Renal Function in Patients with Diabetes: A Systematic Review and Meta-Analysis
    Satoshi Ida, Ryutaro Kaneko, Kanako Imataka, Kazuya Murata · 2019 · Journal of Diabetes Research
70. Urinary Kidney Injury Molecule 1 (KIM-1) and Interleukin 18 (IL-18) as Risk Markers for Heart Failure in Older Adults: The Health, Aging, and Body Composition (Health ABC) Study
    Todd H. Driver, Ronit Katz, Joachim H. Ix, Jared W. Magnani, Carmen Alicia Peralta, Chirag R. Parikh, Linda F. Fried, Anne B. Newman, Stephen B. Kritchevsky, Mark J. Sarnak et al. · 2014 · American Journal of Kidney Diseases
71. Impact of pneumonia and lung cancer on mortality of women with hypertension
    Yuechun Shen, Zuojun Tian, Dongfeng Lu, Junyao Huang, Zuopeng Zhang, Xinchun Li, Jun Li · 2016 · Scientific Reports
72. Sodium–glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes
    Giugliano, Dario, Longo, Miriam, Scappaticcio, Lorenzo, Caruso, Paola, Esposito, Katherine · 2021 · Cardiovascular Diabetology
73. Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status
    Craig J. Currie, Ellen R. Berni, Thomas R. Berni, Sara Jenkins‐Jones, Marvin V. Sinsakul, Lutz Jermutus, Phil Ambery, Meena Jain · 2019 · PLoS ONE
74. Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney Disease
    Esther de Beus, Michiel L. Bots, Arjan D. van Zuilen, Jack F.M. Wetzels, Peter J. Blankestijn · 2015 · Hypertension
75. Activation of Glycogen Synthase Kinase 3β Ameliorates Diabetes-induced Kidney Injury
    Meenalakshmi M. Mariappan, Sanjay Prasad, Kristin M. D’Silva, Esteban Cedillo, Kavithalakshmi Sataranatarajan, Jeffrey L. Barnes, Goutam Ghosh Choudhury, Balakuntalam S. Kasinath · 2014 · Journal of Biological Chemistry
76. Chronic kidney disease and the short-term risk of mortality and amputation in patients hospitalized for peripheral artery disease
    Philippe Lacroix, Victor Aboyans, Ileana Désormais, Thierry Kowalsky, Jean Pierre Cambou, J. Constans, Alessandra Bura-Rivière · 2013 · Journal of Vascular Surgery
77. The goal of blood pressure in the hypertensive patient with diabetes is defined: now the challenge is go from recommendations to practice
    Patricio A López-Jaramillo, José López-López, Cristina Lopez-Lopez, Miguel I Rodriguez-Alvarez · 2014 · Diabetology & Metabolic Syndrome
78. Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria
    Gemma E. Currie, Bernt Johan von Scholten, Sheon Mary, Jose Luis Flores-Guerrero, Morten Kofod Lindhardt, Henrik Reinhard, Peter Karl Jacobsen, William Mullen, Hans‐Henrik Parving, Harald Mischak et al. · 2018 · Cardiovascular Diabetology
79. Lumos for the long trail: Strategies for clinical diagnosis and severity staging for diabetic polyneuropathy and future directions
    Tatsuhito Himeno, Hideki Kamiya, Jiro Nakamura · 2019 · Journal of Diabetes Investigation
80. Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKD
    Dominik Steubl, Markus Peter Schneider, Heike Meiselbach, Jennifer Nadal, Matthias C. Schmid, Turgay Saritas, Vera Krane, Claudia Sommerer, Seema Baid‐Agrawal, Jakob G. J. Voelkl et al. · 2020 · Clinical Journal of the American Society of Nephrology
81. Prevalence of Hypertension and Albuminuria in Pediatric Type 2 Diabetes
    Milena Cioana, Jiawen Deng, Maggie Hou, Ajantha Nadarajah, Yuan Qiu, Sondra Song Jie Chen, Angelica Rivas, Laura E. Banfield, Rahul Chanchlani, Allison B. Dart et al. · 2021 · JAMA Network Open
82. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes
    Gregory A. Nichols, Anouk Déruaz‐Luyet, Kimberly Goodnow Brodovicz, Teresa M. Kimes, A. Gabriela Rosales, Sibylle Jenny Hauske · 2020 · BMC Nephrology
83. Parallel-Group 8-Week Study on Chlorthalidone Effects in Hypertensives With Low Kidney Function
    Massimo Círillo, Fabiana Marcarelli, Alessandra Antonia Mele, Massimo Romanò, Cinzia Lombardi, Giancarlo Bilancio · 2014 · Hypertension
84. Use of Biomarkers in Predicting the Onset, Monitoring the Progression, and Risk Stratification for Patients with Type 2 Diabetes Mellitus
    Benjamin M. Scirica · 2016 · Clinical Chemistry
85. Diabetes: An Update on the Pandemic and Potential Solutions
    Mohammed Kumail Ali, Karen R. Siegel, Eeshwar K Chandrasekar, Nikhil Tandon, Pablo Aschner Montoya, Jean Claude Mbanya, Juliana C.N. Chan, Ping Zhang, K.M. Venkat Narayan · 2017 · World Bank, Washington, DC eBooks
86. Systemic Inflammation Precedes Microalbuminuria in Diabetes
    Florian Gunnar Scurt, Jan Menne, Sabine Brandt, Anja Bernhardt, Peter Rene Mertens, Hermann G. Haller, Christos Chatzikyrkou, Sadayoshi Ito, Josphe L. Izzo, Andrzeij Januszewicz et al. · 2019 · Kidney International Reports
87. The Changing Nature of Mortality and Morbidity in Patients with Diabetes
    Pearson-Stuttard, Jonathan, Buckley, James, Cicek, Meryem, Gregg, Edward W. · 2021 · Endocrinology and Metabolism Clinics of North America
88. Long-term Medical Outcomes of Living Kidney Donors
    Arthur J. Matas, Andrew D. Rule · 2022 · Mayo Clinic Proceedings
89. Pregnancy in Chronic Kidney Disease: questions and answers in a changing panorama
    Giorgina Barbara Piccoli, Gianfranca Cabiddu, Rossella Attini, Federica Neve Vigotti, Federica Fassio, Alessandro Rolfo, Domenica Giuffrida, Antonello Pani, Piero Gaglioti, Tullia Todros · 2015 · Best Practice & Research Clinical Obstetrics & Gynaecology
90. (Pro)renin receptor regulates autophagy and apoptosis in podocytes exposed to high glucose
    Caixia Li, Helmy M. Siragy · 2015 · American Journal of Physiology-Endocrinology and Metabolism
91. The association between estimated glomerular filtration rate, albuminuria, and risk of cardiovascular hospitalizations and all-cause mortality among patients with type 2 diabetes
    Gregory A. Nichols, Anouk Déruaz‐Luyet, Sibylle Jenny Hauske, Kimberly Goodnow Brodovicz · 2017 · Journal of Diabetes and its Complications
92. Long-term effects of intensive glycemic and blood pressure control and fenofibrate use on kidney outcomes
    Mottl, Amy K., Buse, John B., Ismail-Beigi, Faramarz, Sigal, Ronald J., Pedley, Carolyn F., Papademetriou, Vasilios, Simmons, Debra L., Katz, Lois, Mychaleckyj, Josyf C., Craven, Timothy E. · 2018 · Clinical Journal of the American Society of Nephrology
93. Choroidal and retinal thinning in chronic kidney disease independently associate with eGFR decline and are modifiable with treatment
    Tariq E. Farrah, Dan Pugh, Fiona A. Chapman, Emily Godden, Craig Balmforth, Gabriel C. Oniscu, David John Webb, Baljean Dhillon, James W. Dear, Matthew A. Bailey et al. · 2023 · Nature Communications
94. Measures of atherosclerotic burden are associated with clinically manifest cardiovascular disease in type 2 diabetes: a European cross‐sectional study
    Angela C. Shore, Helen Martina Colhoun, Andrea Natali, Carlo Palombo, Gerd Östling, Kunihiko Aizawa, Cecilia Kennbäck, Francesco Casanova, Margaretha Persson, Kim M. Gooding et al. · 2015 · Journal of Internal Medicine
95. Lifetime benefits of early detection and treatment of diabetic kidney disease
    Julia Thornton Snider, Jeffrey H. Sullivan, Emma A. van Eijndhoven, Michael K. Hansen, Nobel Bellosillo, Cheryl A. Neslusan, Ellen S. O’Brien, Ralph J. Riley, Seth A. Seabury, B.L. Kasiske · 2019 · PLoS ONE
96. Uraemic dyslipidaemia revisited: role of high-density lipoprotein
    Thimoteus Speer, Stephen Zewinger, Danilo Fliser · 2013 · Nephrology Dialysis Transplantation
97. Acute and chronic kidney complications in children with type 1 diabetes mellitus
    Giulio Rivetti, Brenden E. Hursh, Emanuele Miraglia del Giudice, Pierluigi Marzuillo · 2022 · Pediatric Nephrology
98. Elevated neutrophil percentage-to-albumin ratio predicts increased all-cause and cardiovascular mortality among individuals with diabetes
    Xiaofan Li, Zhaoyan Gu, Jianjun Gao · 2024 · Scientific Reports
99. Coronary Artery Calcium Assessment in CKD: Utility in Cardiovascular Disease Risk Assessment and Treatment?
    Ahmed Muhammad Bashir, William Edward Moody, Nicola C. Edwards, Charles Joseph Ferro, John Townend, Richard Paul Steeds · 2015 · American Journal of Kidney Diseases
100. Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study
     Mario Gennaro Cozzolino, Markus Ketteler, Kevin J. Martin, Amit Kumar Sharma, David J.A. Goldsmith, Samina S. Khan · 2014 · Nephrology Dialysis Transplantation